LANXESS Aktiengesellschaft (ETR:LXS)

Market Cap	1.09B -40.3%
Revenue (ttm)	5.55B -9.8%
Net Income	-669.00M
EPS	-7.75
Shares Out	86.35M
PE Ratio	n/a
Forward PE	20.39
Dividend	0.10 (0.81%)
Ex-Dividend Date	May 22, 2026

Volume	550,968
Open	12.32
Previous Close	12.60
Day's Range	12.21 - 12.54
52-Week Range	11.03 - 22.02
Beta	1.14
Analysts	Hold
Price Target	16.77 (+35.24%)
Earnings Date	Nov 5, 2026

About ETR:LXS

LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the ag...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1863
• Employees: 11,495
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: LXS

Financial Performance

In 2025, ETR:LXS's revenue was 5.67 billion, a decrease of -10.89% compared to the previous year's 6.37 billion. Losses were -577.00 million, 226.0% more than in 2024.

Analyst Summary

According to 14 analysts, the average rating for LXS stock is "Hold." The 12-month stock price target is €16.77, which is an increase of 35.24% from the latest price.

Price Target

€16.77

(35.24% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 1, 2026

Data Sources Report a data error